CA3295865A1 - Compositions contenant des cellules progénitrices endothéliales isolées et leurs utilisations - Google Patents

Compositions contenant des cellules progénitrices endothéliales isolées et leurs utilisations

Info

Publication number
CA3295865A1
CA3295865A1 CA3295865A CA3295865A CA3295865A1 CA 3295865 A1 CA3295865 A1 CA 3295865A1 CA 3295865 A CA3295865 A CA 3295865A CA 3295865 A CA3295865 A CA 3295865A CA 3295865 A1 CA3295865 A1 CA 3295865A1
Authority
CA
Canada
Prior art keywords
compositions
progenitor cells
endothelial progenitor
isolated endothelial
isolated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3295865A
Other languages
English (en)
Inventor
Paul COLDITZ
Kiarash KHOSROTEHRANI
Simranpreet KAUR
Original Assignee
University of Queensland UQ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Queensland UQ filed Critical University of Queensland UQ
Publication of CA3295865A1 publication Critical patent/CA3295865A1/fr
Pending legal-status Critical Current

Links

CA3295865A 2023-06-29 2024-06-28 Compositions contenant des cellules progénitrices endothéliales isolées et leurs utilisations Pending CA3295865A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2309945.0 2023-06-29

Publications (1)

Publication Number Publication Date
CA3295865A1 true CA3295865A1 (fr) 2025-01-02

Family

ID=

Similar Documents

Publication Publication Date Title
AU2022254330A1 (en) Cell hydrolysate composition from cultivated cells and applications thereof
EP4251175A4 (fr) Compositions de cellules adipogéniques et procédés
CA3261254A1 (fr) Compositions anti-vieillissement enrichies en arn et leurs utilisations
AU2023390890A1 (en) T cell manufacturing compositions and methods
CA3293102A1 (fr) Cellules car-thytreg, compositions et utilisations de celles-ci en immunothérapie
HK40118067A (en) Primed uterine-derived regenerative cell compositions and uses thereof
CA3284655A1 (fr) Cellules immunomodulatrices et compositions
HK40122997A (en) Pathology-responsive recombinant cells and uses thereof
CA3295099A1 (fr) Compositions et leurs utilisations
CA3295097A1 (fr) Compositions et leurs utilisations
CA3292483A1 (fr) Compositions de maribavir et leurs utilisations
AU2023903761A0 (en) Compositions and uses thereof
HK40128580A (en) Compositions and uses thereof
HK40127555A (en) Compositions and uses thereof
AU2023902369A0 (en) Compositions and uses thereof
AU2022901597A0 (en) Compositions and uses thereof
AU2022901030A0 (en) Compositions and uses thereof
AU2022900574A0 (en) Compositions and uses thereof
HK40101917A (en) Tigit engineered cells and compositions thereof
CA3300566A1 (fr) Cellules modifiées et utilisations associées
HK40107091A (en) Cell hydrolysate composition from cultivated cells and applications thereof
CA3298248A1 (fr) Compositions comprenant du difluoropropène et leurs utilisations
AU2022903088A0 (en) Modified T cells and uses thereof
HK40108001A (en) Cell selection methods and related compositions
HK40128910A (zh) 用於细胞特异性表现的组合物及其用途